Patents by Inventor Ariane Biquand

Ariane Biquand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Dilated Cardiomyopathies
    Publication number: 20230277540
    Abstract: The invention relates to the treatment of dilated cardiomyopathies, in particular genetic dilated cardiomyopathies, using non-expressible inhibitors of the WNT pathway or TGF-? pathway, alone or in combination.
    Type: Application
    Filed: June 9, 2021
    Publication date: September 7, 2023
    Applicants: Genethon, Universite d'Evry Val d'Essonne, Institut National de la Santé et de la Recherche Médicale
    Inventors: Isabelle Richard, Ariane Biquand
  • Treatment of Genetic Dilated Cardiomyopathies
    Publication number: 20230265427
    Abstract: The invention relates to the treatment of genetic dilated cardiomyopathies using expressible modulators of the Wnt pathway or TGF-? pathway, preferably using gene transfer.
    Type: Application
    Filed: June 9, 2021
    Publication date: August 24, 2023
    Applicants: Genethon, Institut National de la Santé et de la Recherche Médicale, Universite d'Evry Val d'Essonne
    Inventors: Isabelle RICHARD, Ariane BIQUAND
  • CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies
    Publication number: 20230220391
    Abstract: The present disclosure relates to the treatment of dilated cardiomyopathies, in particular to 5 the use of an inhibitor of CILP-1.
    Type: Application
    Filed: June 9, 2021
    Publication date: July 13, 2023
    Applicants: Genethon, Universite d'Evry Val d'Essonne, Institut National de la Santé et de la Recherche Médicale
    Inventors: Isabelle Richard, Ariane Biquand